|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-20 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-15 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 6.79M 5.88M 5.49M 5.03M 9.47M 647M 9.61M 64.25M 25.23M 324M 25.5M 24.94M 1.07B | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 8.94M 7.73M 7.22M 6.62M 12.46M 851M 12.65M 84.54M 33.2M 426M 33.55M 32.82M 1.41B | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 2024-03-07 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 2024-03-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 2011-12-31 |
William Resides
BRD | Director/Board Member | 57 | 2024-03-07 |
Suzanne Bird
BRD | Director/Board Member | 61 | 2024-03-07 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.34M 2.02M 1.89M 1.73M 3.26M 223M 3.31M 22.14M 8.69M 112M 8.79M 8.59M 369M | 1.85M 1.6M 1.5M 1.37M 2.59M 177M 2.62M 17.54M 6.89M 88.4M 6.96M 6.81M 293M |
| Net income | -23.05M -19.95M -18.63M -17.09M -32.15M -2.19B -32.62M -218M -85.64M -1.1B -86.56M -84.67M -3.64B | -1.54M -1.34M -1.25M -1.14M -2.15M -147M -2.18M -14.6M -5.73M -73.58M -5.8M -5.67M -244M |
| Net Debt | 2.11M 1.82M 1.7M 1.56M 2.94M 200M 2.98M 19.92M 7.82M 100M 7.91M 7.73M 332M | 2.15M 1.86M 1.73M 1.59M 2.99M 204M 3.04M 20.29M 7.97M 102M 8.05M 7.88M 339M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















